1832 Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-234,000
| Closed | -$1.86M | – | 753 |
|
|
2016
Q1 | $1.86M | Hold |
234,000
| – | – | ﹤0.01% | 391 |
|
|
2015
Q4 | $1.16M | Hold |
234,000
| – | – | 0.01% | 391 |
|
|
2015
Q3 | $827K | Sell |
234,000
-133,000
| -36% | -$470K | ﹤0.01% | 404 |
|
|
2015
Q2 | $3.66M | Sell |
367,000
-36,800
| -9% | -$367K | 0.01% | 363 |
|
|
2015
Q1 | $5.15M | Buy |
403,800
+92,300
| +30% | +$1.18M | 0.02% | 287 |
|
|
2014
Q4 | $4.4M | Buy |
+311,500
| New | +$4.4M | 0.01% | 350 |
|